Reve Technologies, Inc. (BSSP)

USD 0.0

(0.0%)

Market Cap (In USD)

37.18 Thousand

Revenue (In USD)

-

Net Income (In USD)

-441.36 Thousand

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-6-1.0E-4
PE
-
EPS
-
Beta Value
0.0
ISIN
US0702491079
CUSIP
070249107
CIK
1495028
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Dennis R. Alexander
Employee Count
-
Website
https://www.cantechpharma.com
Ipo Date
2012-12-13
Details
Reve Technologies, Inc., a drug development company, provides advanced therapeutics for the treatment of cancer. It offers irreversible pepsin fraction (IPF), a therapeutic platform technology that is used to facilitate a range of applications. The company's solution is also used for the treatment of autoimmune diseases, such as cirrhosis and Hepatitis C. The company was founded in 2010 and is based in San Clemente, California.